Emerging Eye Medications: New Treatments to Watch

Over 285 million people worldwide live with some form of vision impairment. New medications offer hope for many. Let's explore treatments currently in development.

Gene Therapy for Inherited Retinal Diseases

Gene therapy is a cutting-edge approach for inherited retinal diseases, which are genetic disorders affecting the retina. Luxturna, approved by the FDA in 2017, was the first of its kind, specifically for patients with a confirmed mutation in the RPE65 gene, which causes retinal dystrophy.

Next-Gen Candidates

Following Luxturna's success, new candidates are emerging. AGTC-501, targeting X-linked retinitis pigmentosa (an inherited condition causing vision loss), is in early trials. Recent results show potential improvements in visual function. Verify trial status with your eye doctor for the latest information.

New Anti-VEGF Agents for Wet AMD

Wet Age-related Macular Degeneration (AMD) affects over 1.4 million Americans, causing vision loss. Anti-VEGF agents, like Eylea and Lucentis, slow disease progression by inhibiting a protein that promotes abnormal blood vessel growth.

Faricimab

Faricimab, in advanced trials, targets two pathways involved in blood vessel growth, potentially reducing injection frequency. Ongoing studies, such as TENAYA and LUCERNE, aim to confirm its benefits.

Emerging Dry Eye Biologics

Dry eye syndrome, affecting 16 million Americans, causes discomfort and vision issues. Traditional treatments often fall short, but new biologics are showing promise.

Tivanisiran

Tivanisiran, an innovative treatment in late-stage trials, targets inflammation by blocking the TRPV1 pathway, a protein linked to pain and inflammation. Consult your eye doctor to verify the latest trial updates.

Questions to Ask Your Eye Doctor About New Treatments

• Are there new treatments available for my condition?
• What are the potential benefits and risks of these treatments?
• How do these new options compare to my current treatment?
• When will these medications be available?

Conclusion

Staying informed about emerging eye medications can help you make better decisions about your eye health. With advancements in gene therapy, anti-VEGF agents, and dry eye biologics, the future holds promise. Discuss these developments with your eye care professional to understand how they may benefit you.